FDA Approves Roszet

FDA Approves Roszet (rosuvastatin and ezetimibe) to Reduce LDL-C in Hyperlipidemia and Homozygous Familial Hypercholesterolemia Morristown, N.J. March 31, 2021 — Althera Pharmaceuticals, a company […]

Read more

Atrovent UDV

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ATROVENT UDVS CMI0119-05 Atrovent 250 µg/1 mL and Atrovent Adult 500 µg/1 […]

Read more

GenRx Alprazolam

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. GENRX ALPRAZOLAM contains the active ingredient, alprazolam (al-PRAZ-oh-lam) Consumer Medicine Information What […]

Read more
1 2 3 18